[1]
Prajapati, K., Hasumati, R., Jain, V. and Prajapati, N. 2016. Pharmacology of Combined Mesalzine and Rifaximin Therapy for Inflammatory Bowel Disease. PharmaTutor. 4, 5 (May 2016), 41-45.